Abcam, ab261863, Human TGFBR2 (TGF beta Receptor II) knockout A549 cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
Human TGFBR2 (TGF beta Receptor II) knockout A549 cell line (ab261863) available to order. Recommended control: Human wild-type (WT) A549 cell line (ab255450). - TGFBR2 KO validation: Next Generation Sequencing (NGS), Western blot - Concentration: 1 million cells/vial
Key facts
Cell type:A549,
Species or organism:Human,
Tissue:Lung,
Form:LiquidSee storage information,
Knockout validation:Next Generation Sequencing,Western blot,
Mutation description:Knockout achieved by CRISPR/Cas9 X = 1 bp insertion Frameshift = 97%,
Disease:Carcinoma

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-TGFBR2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Next Generation Sequencing, Western blot, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C